A BCR-ABL1 cutoff of 1.5% at 3 months, determined by the...

PLoS ONE 2017 / 3 Vol. 12; Iss. 3

A BCR-ABL1 cutoff of 1.5% at 3 months, determined by the GeneXpert system, predicts an optimal response in patients with chronic myeloid leukemia

García-Gutiérrez, Valentín, Gómez-Casares, María T., Puerta, José M., Alonso-Domínguez, Juan M., Osorio, Santiago, Hernández-Boluda, Juan C., Collado, Rosa, Ramírez, María J., Ibáñez, Fátima, Martín,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
12
Language:
english
Journal:
PLOS ONE
DOI:
10.1371/journal.pone.0173532
Date:
March, 2017
File:
PDF, 768 KB
english, 2017
Conversion to is in progress
Conversion to is failed